$339.05
0.38%
NYSE, Jan 02, 10:00 pm CET
ISIN
US03073E1055
Symbol
COR

Cencora Stock price

$338.87
-11.80 3.37% 1M
+47.70 16.38% 6M
+1.12 0.33% YTD
+114.13 50.78% 1Y
+173.16 104.50% 3Y
+242.37 251.16% 5Y
+237.00 232.65% 10Y
+318.17 1,537.05% 20Y
NYSE, Closing price Fri, Jan 02 2026
+1.12 0.33%

New AI Insights on Cencora Insights AI Insights on Cencora

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Key metrics

Basic
Market capitalization
$65.7b
Enterprise Value
$69.0b
Net debt
$3.3b
Cash
$4.4b
Shares outstanding
193.9m
Valuation (TTM | estimate)
P/E
42.3 | 19.0
P/S
0.2 | 0.2
EV/Sales
0.2 | 0.2
EV/FCF
21.5
P/B
43.6
Dividends
DPS
$2.20
Yield 1Y | 5Y
0.7% | 1.1%
Growth 1Y | 5Y
7.8% | 5.8%
Payout 1Y | 3Y
27.6% | 25.7%
Increased
20 Years
Financials (TTM | estimate)
Revenue
$321.3b | $344.5b
EBITDA
$4.8b | $5.3b
EBIT
$3.7b | $4.7b
Net Income
$1.6b | $3.5b
Free Cash Flow
$3.2b
Growth (TTM | estimate)
Revenue
9.3% | 7.2%
EBITDA
16.1% | 9.7%
EBIT
23.2% | 24.5%
Net Income
3.0% | 122.1%
Free Cash Flow
7.0%
Margin (TTM | estimate)
Gross
3.5%
EBITDA
1.5% | 1.5%
EBIT
1.2%
Net
0.5% | 1.0%
Free Cash Flow
1.0%
Financial Health
Equity Ratio
2.0%
Return on Equity
103.1%
ROCE
20.0%
ROIC
-
Debt/Equity
5.1
More
EPS
$8.0
FCF per Share
$16.5
Short interest
4.3%
Employees
44k
Rev per Employee
$7.3m
Show more

Is Cencora a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,082 stocks worldwide.

Cencora Stock Analysis

Unlock Scores for Free

Analyst Opinions

21 Analysts have issued a Cencora forecast:

16x Buy
76%
5x Hold
24%

Analyst Opinions

21 Analysts have issued a Cencora forecast:

Buy
76%
Hold
24%

Financial data from Cencora

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
321,333 321,333
9% 9%
100%
- Direct Costs 310,041 310,041
9% 9%
96%
11,292 11,292
15% 15%
4%
- Selling and Administrative Expenses 6,494 6,494
15% 15%
2%
- Research and Development Expense - -
-
-
4,798 4,798
16% 16%
1%
- Depreciation and Amortization 1,051 1,051
4% 4%
0%
EBIT (Operating Income) EBIT 3,747 3,747
23% 23%
1%
Net Profit 1,554 1,554
3% 3%
0%

In millions USD.

Don't miss a Thing! We will send you all news about Cencora directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Cencora Stock News

Positive
Reuters
20 days ago
U.S. drug distributor Cencora said on Monday it will take majority control of cancer care network OneOncology in a deal that values the business at $7.4 billion, as it moves to expand services for community oncology practices.
Neutral
Business Wire
20 days ago
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced it has entered into a definitive agreement to acquire the majority of the outstanding equity interests that it does not currently own in OneOncology, a physician-led national platform empowering independent medical specialty practices rooted in oncology, from TPG, a leading global alternative asset management firm. “W...
Neutral
Business Wire
about one month ago
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, a global pharmaceutical solutions company, today announced investments to enhance its third-party logistics (3PL) capabilities in the United States and Europe, expanding its global network and strengthening the specialty logistics services it can deliver to pharmaceutical companies worldwide. As more specialty pharmaceuticals reach the market and the...
More Cencora News

Company Profile

AmerisourceBergen Corp. engages provision of pharmaceutical products and business solutions that improve access to care. It operates through the Pharmaceutical Distribution Services and Other segments. The Pharmaceutical Distribution Services segment distributes a comprehensive offering of brand-name, specialty brand-name & generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies & equipment, outsourced compounded sterile preparations, and related services to a wide variety of healthcare providers, including acute care hospitals and health systems, independent & chain retail pharmacies, mail order pharmacies, medical clinics, long-term care & alternate site pharmacies, and other customers. The Other segment focuses on global commercialization services and animal health and includes ABCS, World Courier, and MWI. The company was founded in 1947 and is headquartered in Chesterbrook, PA.

Head office United States
CEO Robert Mauch
Employees 44,000
Founded 1947
Website www.cencora.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today